Category: Vaccines
Global Vaccines
-
Microcarriers Market by Product (Consumables, Equipment), Application (Biologics Manufacturing, Cell Therapy, Vaccine Manufacturing), End User - Global Forecast 2024-2030
... USD 2.37 billion in 2024, at a CAGR 9.99% to reach USD 4.22 billion by 2030. Microcarriers are small spherical beads made from materials such as dextran, polystyrene, gelatin, or glass that provide a surface ... Read More
-
Adult Bovine Serum Market by Origin (Australia-Sourced, New Zealand-Sourced, North America-Sourced), Application (Bioprocessing, Cell Culture, Vaccine Production), End-User - Global Forecast 2024-2030
... 2023 and expected to reach USD 148.18 million in 2024, at a CAGR 5.61% to reach USD 205.99 million by 2030. Adult bovine serum (ABS) is an animal-derived serum extracted from the blood of adult ... Read More
-
COVID-19 Clinical Trials Market by Product (Therapeutics, Vaccines), Phase (Phase I, Phase II, Phase III) - Global Forecast 2024-2030
... to reach USD 6.79 billion in 2024, at a CAGR 13.93% to reach USD 14.84 billion by 2030. The COVID-19 clinical trials market comprises all research activities and trials to examine the efficacy and safety ... Read More
-
Vaccines Market by Type (Monovalent Vaccine, Multivalent Vaccine), Technology Type (Inactivated Vaccines, Live-Attenuated Vaccines, Messenger RNA (mRNA) Vaccines), Indication, Route of administration, Age Group - Global Forecast 2024-2030
... USD 55.66 billion in 2023 and expected to reach USD 59.94 billion in 2024, at a CAGR 7.79% to reach USD 94.14 billion by 2030. Vaccines are biological preparations that equip the body's immune system ... Read More
-
Foot & Mouth Disease Vaccines Market by Product (Conventional, Emergency), Type (DNA Vaccines, Inactivated Vaccines, Live Attenuated Vaccines), Application, Distribution Channel - Global Forecast 2024-2030
... at USD 2.69 billion in 2023 and expected to reach USD 2.93 billion in 2024, at a CAGR 9.10% to reach USD 4.95 billion by 2030. Foot and mouth disease vaccines are biologics designed to ... Read More
-
Healthcare Distribution Market - By Type (Pharmaceutical [OTC, Generic, Branded Drugs], Biopharmaceutical [Vaccines, Monoclonal Antibodies], & Medical Device Distribution Services), End-use (Hospital, Retail Pharmacies) – Global Forecast (2024 – 2032)
... demonstrate a 7.1% CAGR between 2024 and 2032, propelled by innovations in warehouse management systems (WMS) and a heightened focus on patient safety. Advanced WMS technologies improve efficiency, accuracy, and regulatory compliance, ensuring the secure ... Read More
-
Global AAV Contract Development and Manufacturing Organizations Market Size Study, by Workflow (Upstream Processing, Downstream Processing), by Culture Type, by Application (Cell & Gene Therapy Development, Vaccine Development, Biopharmaceutical & Pharmaceutical Discovery, Biomedical Research), by End-User and Regional Forecasts 2022-2032
... End-User and Regional Forecasts 2022-2032 Global AAV Contract Development and Manufacturing Organizations Market is valued at approximately USD 621 million in 2023 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Messenger RNA (mRNA)-based Vaccines and Therapeutics – Market Insight, Epidemiology, and Market Forecast – 2034
... an in-depth understanding of the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics, historical and forecasted epidemiology as well as the Global Messenger RNA (mRNA)-based Vaccines and Therapeutics market trends in the United States, EU5 (Germany, ... Read More
-
Hepatitis B Vaccine Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... valued at USD 8.38 billion in 2023, and the market is now projected to grow from to USD 8.85 billion in 2024 to USD 13.31 billion by 2032, exhibiting a CAGR of 5.2% during the ... Read More
-
Global Continuous Bioprocessing Market Size study & Forecast, by Product (Filtration Systems and Consumables, Chromatography Systems and Consumables, Bioreactors, Sterilizers, Centrifuges, Others), by Application (Commercial, Vaccines, mAb production, Recombinant Protein Production, Cell and Gene Therapy Production, R&D), by End User and Regional Analysis, 2023-2030
... Production, R&D), by End User and Regional Analysis, 2023-2030 Global Continuous Bioprocessing Market is valued at approximately USD 125.6 million in 2022 and is anticipated to grow with a healthy growth rate of more than ... Read More
-
Global Animal Health Market (Feed Additives, Pharmaceuticals & Vaccines): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... at a CAGR of 6.31% for the period spanning 2024-2028. The factors such as growing middle class population, rising cattle/cow population, surge in demand for animal protein, rising U.S. expenditure on pets and growing urbanization ... Read More
-
Cancer Immunotherapy Market Share, Size, Trends, Industry Analysis Report By Type (Monoclonal Antibodies, Cancer Vaccines, Check Point Inhibitors & Immunomodulators); By Application (Lung Cancer, Breast Cancer, Colorectal Cancer, Melanoma, Prostate Cancer, Head & Neck Cancer); By End-user (Hospital, Clinics, Others); By Regions, Segments & Forecast, 2024 - 2032
... By End-user (Hospital, Clinics, Others); By Regions, Segments & Forecast, 2024 - 2032 The global cancer immunotherapy market size is expected to reach USD 261.39 billion by 2032 according to a new study by Polaris ... Read More
-
Active Pharmaceutical Ingredient (API) Market Share, Size, Trends, Industry Analysis Report, By Product Type (mAb, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2024 - 2032
... Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application; By Regions; Segment Forecast, 2024 - 2032 The global active pharmaceutical ingredient (API) market size is expected to ... Read More
-
Global Human Combination Vaccines Market 2024-2028
... period. Our report on the human combination vaccines market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Biologics Safety Testing Market by Product & Service (Consumables, Instrument, Services), Test Type (Mycoplasma, Sterility, Endotoxin, Bioburden, Virus Safety), Application (Vaccines, mAbs, Cell & Gene Therapy, Blood Products) - Global Forecast to 2029
... safety testing market is projected to reach USD 7.2 billion by 2029 from an estimated USD 4.2 billion in 2024, at a CAGR of 11.1% from 2024 to 2029. The growth of this market can ... Read More
-
RNA Therapeutics Market Assessment, By Type [RNA Interference Therapeutics, mRNA Therapeutics, Antisense Oligonucleotide Therapeutics, Others], By Product [Vaccines, Drugs], By Indication [Rare Genetic Diseases/Hereditary Diseases, Infectious Diseases, Others], By End-user [Hospitals, Academic Research Centers, Contract Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F
... Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F Global RNA therapeutics market size was valued at USD 23,067.85 million in 2023, expected to reach USD 54,464.95 million in 2031, with a CAGR of 11.25% ... Read More
-
Global Yellow Fever Vaccines Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Yellow Fever Vaccines industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Yellow Fever Vaccines. The report also introduces players ... Read More
-
Microcarrier Market Analysis and Forecast to 2033: By Material Type (Collagen-based, Gelatin-based, Hyaluronic Acid-based, Polystyrene-based, Dextran-based, Modified Polyvinyl Alcohol), Technology (Two-Dimensional, Three-Dimensional), Application (Regenerative Medicine, Cultured Meat Production, Vaccine Production, Cell Therapy, Biologics Manufacturing, Stem Cell Research, Tissue Engineering), Equipment (Bioreactors, Cell Culture Vessels, Centrifuges, Incubators, Cell Counters, Separation Systems, Storage Systems, Processing Systems), Size of Microcarriers [Small (<1,000 µm), Medium (1,000–2,000 µm), Large (>2,000 µm)], End-User (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research Institutes), and Region
... Cell Research, Tissue Engineering), Equipment (Bioreactors, Cell Culture Vessels, Centrifuges, Incubators, Cell Counters, Separation Systems, Storage Systems, Processing Systems), Size of Microcarriers [Small ( 2,000 µm)], End-User (Biopharmaceutical Companies, Contract Research Organizations, Academic and Research ... Read More
-
Global Medical Drone Market Size study, by Drone Type (Rotor Drones, Fixed Wing Drones, Hybrid Drones) By Application (Blood Bank Transportation, Vaccines Transportation, Organs Transportation, Others) By End User (Hospitals, Blood Banks, Government Institutions, Others) and Regional Forecasts 2022-2032
... and Regional Forecasts 2022-2032 Global Medical Drone Market is valued approximately at USD 244.88 million in 2023 and is anticipated to grow with a healthy growth rate of more than 12.4% over the forecast period ... Read More
-
Global Human Papillomavirus (HPV) Vaccines Market - 2024-2031
... of XX% during the forecast period 2024-2031. Human papillomavirus (HPV) is a viral infection that affects the skin, body orifices, and mucus membranes. It is one of the common sexually transmitted infections (STI) transmitted through ... Read More
-
Global Hepatitis B Vaccines Market Research Report 2024
... of 6.45% during the forecast period 2024-2030. North American market for Hepatitis B Vaccines is estimated to increase from $ 568 million in 2023 to reach $ 964 million by 2030, at a CAGR of ... Read More
-
Global Dengue Vaccines Market Growth (Status and Outlook) 2024-2030
... the brand name Dengvaxia. The vaccine is only recommended in those who have previously had dengue fever or populations in which most people have been previously infected. The value of the vaccine is limited by ... Read More
-
2024 Global Forecast for Pediatric Vaccines Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Animal Vaccine Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Chemicals industry. The product or service category is within the NAICS Chemicals industry. The global market is expected to increase from USD xx billion in 2025 to ... Read More
-
2024 Global Forecast for Polio Vaccine Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
Research Assistance
